Toxocara canis meningomyelitis

J Neurol. 2005 Oct;252(10):1267-8. doi: 10.1007/s00415-005-0688-0. Epub 2005 Oct 5.
No abstract available

Publication types

  • Case Reports
  • Letter

MeSH terms

  • Adult
  • Animals
  • Antibodies, Helminth / cerebrospinal fluid
  • Antinematodal Agents / adverse effects
  • Antinematodal Agents / therapeutic use
  • Enzyme-Linked Immunosorbent Assay
  • Eosinophilia / cerebrospinal fluid
  • Eosinophilia / parasitology*
  • Female
  • Follow-Up Studies
  • Humans
  • Magnetic Resonance Imaging
  • Mebendazole / adverse effects
  • Mebendazole / therapeutic use
  • Meningitis / drug therapy
  • Meningitis / parasitology*
  • Myelitis / drug therapy
  • Myelitis / parasitology*
  • Prognosis
  • Time Factors
  • Toxocara canis*
  • Toxocariasis / diagnosis*
  • Toxocariasis / drug therapy
  • Toxocariasis / immunology
  • Treatment Outcome

Substances

  • Antibodies, Helminth
  • Antinematodal Agents
  • Mebendazole